Research summary, original research, 2016

The Effects Of Combining Fusion Imaging, Low-Frequency Pulsed Fluoroscopy, And Low-Concentration Contrast Agent During Endovascular Aneurysm Repair

Dias NV, Billberg H, Sonesson B, Törnqvist P, Resch T, Kristmundsson T. Journal of vascular surgery. 2016

Read the original paper

In plain language

In 226 patients undergoing aortic endovascular repair, combining lower pulse-rate fluoroscopy, fusion imaging and dilute contrast lowered patient dose area product by about 40% without loss of technical success. Staff dose was not measured, though lower patient dose usually means less scatter.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Size
n = 226 patients
Summary based on
the abstract

What it found

  • Patient radiation exposure (dose area product) was lower with the combined protocol than with the prior protocol.

    Key figures: 19,934 [interquartile range (IQR), 11,340-30,615] μGym(2) vs 32,856 [IQR, 19,562-55,677] μGym(2); P < .0001

  • Reducing the frame rate from 7.5 to 3.75 frames/s alone accounted for a median 22% reduction in dose area product.

    Key figures: 22%

  • Iodine dose was substantially lower with the combined protocol.

    Key figures: 14.5 [IQR, 8.8-20.4] g vs 43.0 [IQR, 32.2-56.0] g; P < .0001

  • Technical success, operation time and fluoroscopy time were similar between groups.

    Key figures: 92% and 92%; fluoroscopy 66 vs 72 minutes, P > .05

  • For fenestrated grafts, radiation exposure did not differ, attributed to greater superior mesenteric artery involvement in the new-protocol group.

    Key figures: 81% vs 17%; P < .0001

Limits to keep in mind

Single-centre retrospective before-after comparison with historical controls; only patient dose area product was measured, not staff dose, and several changes were introduced at once.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.